Oncolytics Biotech Inc.: A Year of REOLYSIN’s Triumphs, Global Impact, and Future Frontiers in Immuno-Oncolytic Therapy
In the realm of cutting-edge biotechnology, Oncolytics Biotech Inc. stands as a beacon of innovation. Headquartered in Calgary, Alberta, this Canadian company has been at the forefront of developing a groundbreaking intravenously delivered immuno-oncolytic virus known as pelareorep. This revolutionary therapy is designed for the treatment of solid tumors and hematological malignancies, showcasing its potential…